The PE Ratio as of December 2025 (TTM) for NeuroScientific Biopharmaceuticals Limited (NSB.AX) is -11.00

According to NeuroScientific Biopharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -11.00. This represents a change of 664.39% compared to the average of -1.44 of the last 4 quarters.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Historical PE Ratio (quarterly & annually)

How has NSB.AX PE Ratio performed in the past?

The mean historical PE Ratio of NeuroScientific Biopharmaceuticals Limited over the last ten years is -26.99. The current -11.00 PE Ratio has changed 3.98% with respect to the historical average. Over the past ten years (40 quarters), NSB.AX's PE Ratio was at its highest in in the June 2023 quarter at 1.44. The PE Ratio was at its lowest in in the June 2017 quarter at -38.32.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroScientific Biopharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Average PE Ratio

How has NSB.AX PE Ratio performed in the past?

The current PE Ratio of NeuroScientific Biopharmaceuticals Limited (NSB.AX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

NeuroScientific Biopharmaceuticals Limited (NSB.AX) PE Ratio vs. Peers

How is NSB.AX’s PE Ratio compared to its peers?

NeuroScientific Biopharmaceuticals Limited’s PE Ratio is less than Prescient Therapeutics Limited (-9.27), less than Proteomics International Laboratories Limited (-8.99), less than AnteoTech Limited (-10.52), less than Radiopharm Theranostics Limited (-1.34), less than Cynata Therapeutics Limited (-6.37), less than Doctor Care Anywhere Group PLC (-7.54), less than Argenica Therapeutics Limited (-4.49), less than Amplia Therapeutics Limited (-6.72), less than Next Science Limited (-3.82), less than Noxopharm Limited (-5.92),

Build a custom stock screener for NeuroScientific Biopharmaceuticals Limited (NSB.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroScientific Biopharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroScientific Biopharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.